They are keen to invite consumers to become members of the Group. They have recently carried out a review on vaccines against meningococcal meningitis. They are now looking for a consumer who would be willing to comment on this review. If you are interested please contact Ron DSouza at the address below. Summary of the review Vaccines can protect children over the age of five against meningococcal meningitis, and provides some protection to younger children in developing countries as well.
Meningococcal meningitis is a brain infection caused by bacteria originally from the nose area.
It can progress very quickly to damage the brain, and is often fatal. The review found there was not enough evidence from trials to answer some important questions about vaccination for meningococcal meningitis. However, the vaccine appears to strongly protect children over five years of age. Trials show some protection for children in developing countries from one to five years of age as well.